Literature DB >> 46286

RNA-dependent DNA polymerase activity of RNA tumor viruses. V. Rous sarcoma virus single-stranded RNA-DNA covalent hybrids in infected chicken embryo fibroblast cells.

J Leis, A Schincariol, R Ishizaki, J Hurwitz.   

Abstract

RNA-DNA covalent hybrids containing viral RNA have been isolated from nuclear fractions of Rous sarcoma virus-infected chicken embryo fibroblast cells shortly after virus infection. The formation of covalent hybrid structures depends upon a functional reverse transcriptase in vivo, since its appearance in cells is temperature dependent when infected with Rous sarcoma virus mutant LA335, which contains a temperature-sensitive reverse transcriptase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46286      PMCID: PMC354484     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  EFFECTS OF ACTINOMYCIN D AND OF MITOMYCIN C ON THE DEVELOPMENT OF ROUS SARCOMA VIRUS.

Authors:  P VIGIER; A GOLDE
Journal:  Virology       Date:  1964-08       Impact factor: 3.616

2.  THE PARTICIPATION OF DNA IN ROUS SARCOMA VIRUS PRODUCTION.

Authors:  H M TEMIN
Journal:  Virology       Date:  1964-08       Impact factor: 3.616

3.  THE ROLE OF DEOXYRIBONUCLEIC ACID IN THE SYNTHESIS OF ROUS SARCOMA VIRUS.

Authors:  J P BADER
Journal:  Virology       Date:  1964-04       Impact factor: 3.616

4.  Direction of polymerization by the avian myeloblastosis virus deoxyribonucleic acid polymerase.

Authors:  D Smoler; I Molineux; D Baltimore
Journal:  J Biol Chem       Date:  1971-12-25       Impact factor: 5.157

5.  Covalently linked RNA-DNA molecule as initial product of RNA tumour virus DNA polymerase.

Authors:  I M Verma; N L Meuth; E Bromfeld; K F Manly; D Baltimore
Journal:  Nat New Biol       Date:  1971-09-29

6.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

7.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

8.  Characterization of two conditional early mutants of Rous sarcoma virus.

Authors:  M Linial; W S Mason
Journal:  Virology       Date:  1973-05       Impact factor: 3.616

9.  Penetration and intracellular release of the genomes of avian RNA tumor viruses.

Authors:  S Dales; H Hanafusa
Journal:  Virology       Date:  1972-11       Impact factor: 3.616

10.  Comparative properties of RNA and DNA templates for the DNA polymerase of Rous sarcoma virus.

Authors:  P Duesberg; K V Helm; E Canaani
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

View more
  6 in total

1.  Fate of input oncornavirion RNA--biological studies.

Authors:  M M Sveda; B N Fields; R Soeiro
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

2.  Synthesis of plus strands of retroviral DNA in cells infected with avian sarcoma virus and mouse mammary tumor virus.

Authors:  H J Kung; Y K Fung; J E Majors; J M Bishop; H E Varmus
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

3.  tRNA's associated with the 70S RNA of avian myeloblastosis virus.

Authors:  L C Waters; B C Mullin; E G Bailiff; R A Popp
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

4.  Kinetics of murine type C virus-specific DNA synthesis newly infected cells.

Authors:  G G Lovinger; R Klein; H P Ling; R V Gilden; M Hatanaka
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

5.  Thermolabile reverse transcriptase of a mammalian leukemia virus mutant temperature sensitive in its replication and sarcoma virus helper functions.

Authors:  S R Tronick; J R Stephenson; I M Verma; S A Aaronson
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

6.  Inhibition of oncornavirus functions by poly (2-methylthioinosinic acid).

Authors:  E De Clercq; A Billiau; M Hattori; M Ikehara
Journal:  Nucleic Acids Res       Date:  1975-12       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.